Kiniksa Pharmaceuticals International, plc KNSA

Updated: 11 Aug 2026

NASDAQ | Biotech | Biotechnology and cardiovascular therapeutics

No signal published yet

We already track Kiniksa Pharmaceuticals International and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Kiniksa Pharmaceuticals International free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and cardiovascular therapeutics
We're already tracking Kiniksa Pharmaceuticals International, plc — here are the latest events we've registered

Recent News

  • On July 28, 2026, Kiniksa Pharmaceuticals reported its second-quarter 2026 financial results, generating $243.6 million in ARCALYST net product revenue. The company raised its full-year 2026 net product revenue guidance to $980–$995 million. Additionally, Kiniksa confirmed that patient dosing is underway in the pivotal Phase 3 PASTORALE trial for candidate KPL-387.

What Firelda Watch includes for Kiniksa Pharmaceuticals International, plc

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Kiniksa Pharmaceuticals International, plc will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Recipharm
RECI B
NEUTRAL
Viatris Inc.
VTRS
HOLD
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL

Biotech

More companies in this sector

Want to follow Kiniksa Pharmaceuticals International, plc? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Kiniksa Pharmaceuticals International free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Kiniksa Pharmaceuticals International, plc KNSA
Kiniksa Pharmaceuticals International — follow and we'll monitor it
Follow Kiniksa Pharmaceuticals International free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.